Ocriplasmin: who is the best candidate?
Claudia M Prospero Ponce, William Stevenson, Rachel Gelman, Daniel R Agarwal, John B Christoforidis Retina Division, Department of Ophthalmology, University of Arizona Medical Center, Tucson, AZ, USA Abstract: Enzymatic vitreolysis is currently the focus of attention around the world for treating...
Guardado en:
Autores principales: | Prospero Ponce CM, Stevenson W, Gelman R, Agarwal DR, Christoforidis JB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/513dc210827f4837993822f0cad7cf35 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman S, et al.
Publicado: (2020) -
Clinical characteristics and selection of treatment modality for patients with vitreomacular traction: real-world implementation of NICE guidance (TA297)
por: Pritchard EWJ, et al.
Publicado: (2016) -
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
por: Drenser KA, et al.
Publicado: (2021) -
Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting
por: Reichel E, et al.
Publicado: (2016) -
Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
por: Kulikov AN, et al.
Publicado: (2017)